Search details
1.
Evaluation of Flexible Parametric Relative Survival Approaches for Enforcing Long-Term Constraints When Extrapolating All-Cause Survival.
Value Health
; 27(1): 51-60, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37858887
2.
Perils of Randomized Controlled Trial Survival Extrapolation Assuming Treatment Effect Waning: Why the Distinction Between Marginal and Conditional Estimates Matters.
Value Health
; 27(3): 347-355, 2024 03.
Article
in English
| MEDLINE | ID: mdl-38154594
3.
A cautionary tale: an evaluation of the performance of treatment switching adjustment methods in a real world case study.
BMC Med Res Methodol
; 24(1): 17, 2024 Jan 22.
Article
in English
| MEDLINE | ID: mdl-38253996
4.
Is Intention to Treat Still the Gold Standard or Should Health Technology Assessment Agencies Embrace a Broader Estimands Framework?: Insights and Perspectives From the National Institute for Health and Care Excellence and Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen on the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use E9 (R1) Addendum.
Value Health
; 26(2): 234-242, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36150999
5.
Prevalence of Immature Survival Data for Anti-Cancer Drugs Presented to the National Institute for Health and Care Excellence and Impact on Decision Making.
Value Health
; 24(4): 505-512, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33840428
6.
Self-managed, computerised word finding therapy as an add-on to usual care for chronic aphasia post-stroke: An economic evaluation.
Clin Rehabil
; 35(5): 703-717, 2021 May.
Article
in English
| MEDLINE | ID: mdl-33233972
7.
Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi-stakeholder, international workshop.
BMC Health Serv Res
; 21(1): 412, 2021 May 03.
Article
in English
| MEDLINE | ID: mdl-33941174
8.
Adjusting for Treatment Switching in Oncology Trials: A Systematic Review and Recommendations for Reporting.
Value Health
; 23(3): 388-396, 2020 03.
Article
in English
| MEDLINE | ID: mdl-32197735
9.
Survival Extrapolation in Cancer Immunotherapy: A Validation-Based Case Study.
Value Health
; 22(3): 276-283, 2019 Mar.
Article
in English
| MEDLINE | ID: mdl-30832965
10.
Impact of Nonrandomized Dropout on Treatment Switching Adjustment in the Relapsing-Remitting Multiple Sclerosis CLARITY Trial and the CLARITY Extension Study.
Value Health
; 22(7): 772-776, 2019 07.
Article
in English
| MEDLINE | ID: mdl-31277823
11.
The Cost of Costing Treatments Incorrectly: Errors in the Application of Drug Prices in Economic Evaluation Due to Failing to Account for the Distribution of Patient Weight.
Value Health
; 19(8): 1055-1058, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-27987632
12.
TREATMENT SWITCHING: STATISTICAL AND DECISION-MAKING CHALLENGES AND APPROACHES.
Int J Technol Assess Health Care
; 32(3): 160-6, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-27624982
13.
TREATMENT SWITCHING IN CANCER TRIALS: ISSUES AND PROPOSALS.
Int J Technol Assess Health Care
; 32(3): 167-74, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-27624983
14.
Adjusting for Nonadherence or Stopping Treatments in Randomized Clinical Trials.
JAMA
; 325(20): 2110-2111, 2021 May 25.
Article
in English
| MEDLINE | ID: mdl-34032845
15.
Adjusting for the Confounding Effects of Treatment Switching-The BREAK-3 Trial: Dabrafenib Versus Dacarbazine.
Oncologist
; 20(7): 798-805, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-26040620
16.
Challenges and Opportunities in Interdisciplinary Research and Real-World Data for Treatment Sequences in Health Technology Assessments.
Pharmacoeconomics
; 42(5): 487-506, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38558212
17.
Modelling the cost-effectiveness of alcohol screening and brief interventions in primary care in England.
Alcohol Alcohol
; 48(2): 180-8, 2013.
Article
in English
| MEDLINE | ID: mdl-23015608
18.
Cost-utility of self-managed computer therapy for people with aphasia.
Int J Technol Assess Health Care
; 29(4): 402-9, 2013 Oct.
Article
in English
| MEDLINE | ID: mdl-24290333
19.
A Systematic Review of Methods to Incorporate External Evidence into Trial-Based Survival Extrapolations for Health Technology Assessment.
Med Decis Making
; 43(5): 610-620, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37125724
20.
Survival Extrapolation Incorporating General Population Mortality Using Excess Hazard and Cure Models: A Tutorial.
Med Decis Making
; 43(6): 737-748, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37448102